Patients who experience adverse ocular effects with bisphosphonates have a notably higher risk for osteonecrosis than those who do not experience such events, a large cohort study shows.

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of ...

Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) reported Q3 CY2025 results , but sales fell by 5.7% ...

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the low priced stocks to buy with high upside potential. On December 12, Bank ...

Ocular migraine is associated with visual disturbances and may be related to genetics, as research suggests a significant genetic component in migraine. Hormonal fluctuations, particularly drops in ...

When it comes to migraines, not all headaches are created the same. According to Joey Gee, D.O., neurologist with Providence Mission Hospital, approximately 15 to 25% of migraine sufferers will ...

The live and archived webcast can also be accessed by visiting the Ocular Therapeutix website on the Events and Presentations section of the Investor Relations page. A replay of the webcast will be ...

This prospective study aimed to clinically correlate the various ocular findings with the neurological status in cases of closed head injury. A total of 200 consecutive cases of closed head injury ...

Ocular TB is a rare eye disease due to infection from Mycobacterium tuberculosis, the same bacterium that causes tuberculosis, commonly known as TB. TB symptoms usually start in the lungs, but they ...